Impact of the COVID-19 outbreak on an Italian cohort of systemic sclerosis patients.

Autor: Bellan, M, Parisi, S, Stobbione, P, Pedrinelli, AR, Rizzi, E, Casciaro, GF, Vassia, V, Landi, R, Cittone, MG, Rigamonti, C, Patrucco, F, Ditto, MC, Finucci, A, Realmuto, C, Todoerti, M, Parodi, M, Rossi, P, Pirisi, M, Fusaro, E, Sainaghi, PP

Publikováno v: Scandinavian Journal of Rheumatology; Nov2020, Vol. 49 Issue 6, p505-506, 2p

Spleen stiffness measurement predicts decompensation and rules out high-risk oesophageal varices in primary biliary cholangitis.

Autor: Rigamonti C; Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.; Division of Internal Medicine, AOU Maggiore della Carità, Novara, Italy., Cittone MG; Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.; Division of Internal Medicine, AOU Maggiore della Carità, Novara, Italy., Manfredi GF; Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.; Division of Internal Medicine, AOU Maggiore della Carità, Novara, Italy., De Benedittis C; Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.; Division of Internal Medicine, AOU Maggiore della Carità, Novara, Italy., Paggi N; Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.; Division of Internal Medicine, AOU Maggiore della Carità, Novara, Italy., Baorda F; Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.; Division of Internal Medicine, AOU Maggiore della Carità, Novara, Italy., Di Benedetto D; Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.; Division of Internal Medicine, AOU Maggiore della Carità, Novara, Italy., Minisini R; Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.; Division of Internal Medicine, AOU Maggiore della Carità, Novara, Italy., Pirisi M; Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.; Division of Internal Medicine, AOU Maggiore della Carità, Novara, Italy.

Publikováno v: JHEP reports : innovation in hepatology [JHEP Rep] 2023 Oct 31; Vol. 6 (1), pp. 100952. Date of Electronic Publication: 2023 Oct 31 (Print Publication: 2024).

High reproducibility of spleen stiffness measurement by vibration-controlled transient elastography with a spleen-dedicated module.

Autor: Rigamonti C; Department of Translational MedicineUniversità del Piemonte Orientale and Division of Internal Medicine, Azienda Ospedaliero-Universitaria Maggiore della CaritàNovaraItaly., Cittone MG; Department of Translational MedicineUniversità del Piemonte Orientale and Division of Internal Medicine, Azienda Ospedaliero-Universitaria Maggiore della CaritàNovaraItaly., Manfredi GF; Department of Translational MedicineUniversità del Piemonte Orientale and Division of Internal Medicine, Azienda Ospedaliero-Universitaria Maggiore della CaritàNovaraItaly., Sorge A; Gastroenterology and Endoscopy UnitFondazione IRCCS Ca' Granda-Ospedale Maggiore PoliclinicoMilanItaly., Moia R; Division of Hematology, Department of Translational MedicineUniversità del Piemonte Orientale and Azienda Ospedaliero-Universitaria Maggiore della CaritàNovaraItaly., Patriarca A; Division of Hematology, Department of Translational MedicineUniversità del Piemonte Orientale and Azienda Ospedaliero-Universitaria Maggiore della CaritàNovaraItaly., Donato MF; Gastroenterology and Hepatology UnitFondazione IRCCS Ca' Granda-Ospedale Maggiore PoliclinicoMilanItaly., Gaidano G; Division of Hematology, Department of Translational MedicineUniversità del Piemonte Orientale and Azienda Ospedaliero-Universitaria Maggiore della CaritàNovaraItaly., Pirisi M; Department of Translational MedicineUniversità del Piemonte Orientale and Division of Internal Medicine, Azienda Ospedaliero-Universitaria Maggiore della CaritàNovaraItaly., Fraquelli M; Gastroenterology and Endoscopy UnitFondazione IRCCS Ca' Granda-Ospedale Maggiore PoliclinicoMilanItaly.

Publikováno v: Hepatology communications [Hepatol Commun] 2022 Nov; Vol. 6 (11), pp. 3006-3014. Date of Electronic Publication: 2022 Sep 09.

Genetic and phenotypic attributes of splenic marginal zone lymphoma.

Autor: Bonfiglio F; Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland., Bruscaggin A; Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland., Guidetti F; Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland., Terzi di Bergamo L; Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland., Faderl M; Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland., Spina V; Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland., Condoluci A; Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland.; Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland., Bonomini L; International Extranodal Lymphoma Study Group, Bellinzona, Switzerland., Forestieri G; Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland., Koch R; Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland., Piffaretti D; Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland., Pini K; Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland., Pirosa MC; Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland., Cittone MG; Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland.; Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland., Arribas A; Lymphoma Genomics, Institute of Oncology Research, Bellinzona, Switzerland., Lucioni M; Unit of Anatomic Pathology, Department of Molecular Medicine, Fondazione IRCCS Policlinico San Matteo and Università degli Studi di Pavia, Pavia, Italy., Ghilardi G; Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland., Wu W; Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland., Arcaini L; Division of Hematology, Fondazione IRCCS Policlinico San Matteo and Department of Molecular Medicine, University of Pavia, Pavia, Italy., Baptista MJ; Lymphoid Neoplasms Group, Josep Carreras Leukaemia Research Institute, Badalona, Spain., Bastidas G; Division of Hematology, Hospital Clínic i Provincial de Barcelona, Barcelona, Spain., Bea S; Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS).; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) 28029, Madrid, Spain.; Pathology Department, Hospital Clínic, Barcelona University, Barcelona, Spain., Boldorini R; Division of Pathology, University of Eastern Piedmont, Novara, Italy., Broccoli A; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia Seràgnoli, Bologna, Italy., Buehler MM; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland., Canzonieri V; Pathology Unit, CRO Aviano National Cancer Institute, Aviano, Italy.; Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy., Cascione L; Lymphoma Genomics, Institute of Oncology Research, Bellinzona, Switzerland., Ceriani L; Clinic of Nuclear Medicine and PET-CT Centre, Imaging Institute of Southern Switzerland, Bellinzona, Switzerland., Cogliatti S; Institute of Pathology, Kantonsspital St Gallen, St Gallen, Switzerland., Corradini P; Division of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Derenzini E; Onco-hematology Division, European Institute of Oncology (IEO) IRCCS, Milan, Italy., Devizzi L; Division of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Dietrich S; Division of Hematology, University Hospital Heidelberg, Heidelberg, Germany., Elia AR; Cancer Immunotherapy, Institute of Oncology Research, Bellinzona, Switzerland., Facchetti F; Department of Molecular and Translational Medicine, Pathology Unit, Spedali Civili, Brescia, Italy., Gaidano G; Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy., Garcia JF; Division of Pathology, MD Anderson Cancer Center, Madrid, Spain., Gerber B; Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.; Department of Hematology and Oncology, University of Zurich, Zurich, Switzerland., Ghia P; Strategic Research Program on Chronic Lymphocytic Leukemia (CLL), IRCCS Ospedale San Raffaele and Università Vita-Salute San Raffaele, Milan, Italy., Gomes da Silva M; Division of Hematology, Instituto Português de Oncologia de Lisboa, Lisbon, Portugal., Gritti G; Division of Hematology, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy., Guidetti A; Division of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Hitz F; Division of Hematology, Kantonsspital St Gallen, St Gallen, Switzerland., Inghirami G; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY., Ladetto M; Division of Hematology, Azienda Ospedaliera SS Antonio e Biagio, Alessandria, Italy.; Dipartimento di Medicina Traslazionale, University of Eastern Piedmont, Alessandria, Italy., Lopez-Guillermo A; Division of Lymphoid Neoplasms, Hospital Clínic i Provincial de Barcelona, Barcelona, Spain., Lucchini E; Division of Hematology, Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy., Maiorana A; Division of Pathology, Universitá degli Studi di Modena e Reggio Emilia, Modena, Italy., Marasca R; Hematology Unit, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy., Matutes E; Haematopathology Unit, Hospital Clínic i Provincial de Barcelona, Barcelona, Spain., Meignin V; Division of Pathology, Saint Louis Hospital, Paris, France., Merli M; Division of Hematology, University of Insubria and ASST Sette Laghi, Ospedale di Circolo of Varese, Varese, Italy., Moccia A; Clinic of Medical Oncology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland., Mollejo M; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) 28029, Madrid, Spain.; Division of Pathology, Hospital Virgen de la Salud, Toledo, Spain., Montalban C; Division of Hematology, MD Anderson Cancer Center, Madrid, Spain., Novak U; Department of Medical Oncology and University Cancer Center, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Oscier DG; Division of Hematology, University Hospitals Dorset, Bournemouth, United Kingdom., Passamonti F; Department of Medicine and Surgery, University of Insubria and ASST Sette Laghi, Ospedale di Circolo of Varese, Varese, Italy., Piazza F; Division of Hematology, Ospedale Universitario di Padova, Padova, Italy., Pizzolitto S; Division of Pathology, General Hospital S Maria della Misericordia, Udine, Italy., Rambaldi A; Division of Hematology, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy., Sabattini E; Haematopathology Unit, Department of Experimental Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy., Salles G; Faculté de Médecine et de Maïeutique Lyon Sud, Université de Lyon, Lyon, France., Santambrogio E; Candiolo Cancer Institute (FPO-IRCCS), Candiolo, Turin, Italy., Scarfò L; Strategic Research Program on Chronic Lymphocytic Leukemia (CLL), IRCCS Ospedale San Raffaele and Università Vita-Salute San Raffaele, Milan, Italy., Stathis A; Clinic of Medical Oncology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland., Stüssi G; Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.; Faculty of Biomedical Sciences, Università della Svizzera Italiana (USI), Lugano, Switzerland., Geyer JT; Division of Anatomic Pathology and Clinical Pathology, Weill Cornell Medical College, New York, NY., Tapia G; Division of Pathology, Hospital Germans Trias I Pujol, Universitat Autònoma de Barcelona, Barcelona, Spain., Tarella C; Onco-hematology Division, European Institute of Oncology (IEO) IRCCS, Milan, Italy., Thieblemont C; Assistance Publique-Hôpitaux de Paris, Hopital Saint-Louis, Hemato-Oncology Unit; Université de Paris, Paris, France., Tousseyn T; Department of Haematology, University Hospitals Leuven, Leuven, Belgium., Tucci A; Division of Hematology, Spedali Civili, Brescia, Italy., Vanini G; Department of Medical Oncology and University Cancer Center, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Visco C; Department of Medicine, Section of Hematology, University of Verona, Italy., Vitolo U; Candiolo Cancer Institute (FPO-IRCCS), Candiolo, Turin, Italy., Walewska R; Division of Hematology, University Hospitals Dorset, Bournemouth, United Kingdom., Zaja F; Division of Hematology, Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy., Zenz T; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland., Zinzani PL; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia Seràgnoli, Bologna, Italy.; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy., Khiabanian H; Center for Systems and Computational Biology, Rutgers University, New Brunswick, NJ., Calcinotto A; Cancer Immunotherapy, Institute of Oncology Research, Bellinzona, Switzerland., Bertoni F; Lymphoma Genomics, Institute of Oncology Research, Bellinzona, Switzerland.; Clinic of Medical Oncology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.; Faculty of Biomedical Sciences, Università della Svizzera Italiana (USI), Lugano, Switzerland., Bhagat G; Department of Pathology and Cell Biology, Columbia University, New York, NY., Campo E; Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS).; Pathology Department, Hospital Clínic, Barcelona University, Barcelona, Spain., De Leval L; Division of Pathology, Institut Universitaire de Pathologie, Lausanne, Switzerland., Dirnhofer S; Institute of Pathology and Medical Genetics, University Hospital Basel, Basel, Switzerland., Pileri SA; Haematopathology Division, European Institute of Oncology IRCCS, Milan, Italy., Piris MA; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) 28029, Madrid, Spain.; Pathology Service, Fundación Jiménez Díaz, Madrid, Spain., Traverse-Glehen A; Division of Pathology, Centre Hospitalier Lyon Sud, Lyon, France., Tzankov A; Institute of Pathology and Medical Genetics, University Hospital Basel, Basel, Switzerland., Paulli M; Unit of Anatomic Pathology, Department of Molecular Medicine, Fondazione IRCCS Policlinico San Matteo and Università degli Studi di Pavia, Pavia, Italy., Ponzoni M; Ateneo Vita-Salute San Raffaele University and Pathology Unit San Raffaele Scientific Institute, Milan, Italy., Mazzucchelli L; Division of Pathology, Cantonal Institute of Pathology, Locarno, Switzerland., Cavalli F; Institute of Oncology Research, Bellinzona, Switzerland; and., Zucca E; International Extranodal Lymphoma Study Group, Bellinzona, Switzerland.; Clinic of Medical Oncology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.; Faculty of Biomedical Sciences, Università della Svizzera Italiana (USI), Lugano, Switzerland.; Department of Medical Oncology, Bern University Hospital and University of Bern, Bern, Switzerland., Rossi D; Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland.; Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.; Faculty of Biomedical Sciences, Università della Svizzera Italiana (USI), Lugano, Switzerland.

Publikováno v: Blood [Blood] 2022 Feb 03; Vol. 139 (5), pp. 732-747.

Stiffer Spleen Predicts Higher Bone Marrow Fibrosis and Higher JAK2 Allele Burden in Patients With Myeloproliferative Neoplasms.

Autor: Moia R; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale and Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy., Cittone MG; Division of Internal Medicine, Department of Translational Medicine, Università del Piemonte Orientale and Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy., Boggione P; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale and Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy., Manfredi GF; Division of Internal Medicine, Department of Translational Medicine, Università del Piemonte Orientale and Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy., Favini C; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale and Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy., Awikeh B; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale and Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy., Pedrinelli AR; Division of Internal Medicine, Department of Translational Medicine, Università del Piemonte Orientale and Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy., Mahmoud AM; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale and Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy., Nicolosi M; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale and Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy., Bellan M; Division of Internal Medicine, Department of Translational Medicine, Università del Piemonte Orientale and Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy., Sainaghi PP; Division of Internal Medicine, Department of Translational Medicine, Università del Piemonte Orientale and Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy., Pirisi M; Division of Internal Medicine, Department of Translational Medicine, Università del Piemonte Orientale and Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy., Gaidano G; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale and Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy., Patriarca A; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale and Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy., Rigamonti C; Division of Internal Medicine, Department of Translational Medicine, Università del Piemonte Orientale and Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy.

Publikováno v: Frontiers in oncology [Front Oncol] 2021 Oct 26; Vol. 11, pp. 777730. Date of Electronic Publication: 2021 Oct 26 (Print Publication: 2021).